Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Gaijing Han"'
Autor:
Gaijing Han, Cong Cao, Xi Yang, Guo-Wei Zhao, Xin-Jun Hu, Dong-Lin Yu, Rui-Feng Yang, Ke Yang, Ying-Ying Zhang, Wen-Tian Wang, Xiu-Zhen Liu, Peng Xu, Xue-Hui Liu, Ping Chen, Zheng Xue, De-Pei Liu, Xiang Lv
Publikováno v:
Redox Biology, Vol 50, Iss , Pp 102239- (2022)
In β-thalassemia, free α-globin chains are unstable and tend to aggregate or degrade, releasing toxic heme, porphyrins and iron, which produce reactive oxygen species (ROS). α-Hemoglobin-stabilizing protein (AHSP) is a potential modifier of β-tha
Externí odkaz:
https://doaj.org/article/64bfb4bbf354487e8dff0b3fac47b2bf
Autor:
Gaijing Han, Cong Cao, Xi Yang, Guo-Wei Zhao, Xin-Jun Hu, Dong-Lin Yu, Rui-Feng Yang, Ke Yang, Ying-Ying Zhang, Wen-Tian Wang, Xiu-Zhen Liu, Peng Xu, Xue-Hui Liu, Ping Chen, Zheng Xue, De-Pei Liu, Xiang Lv
Publikováno v:
Redox Biology, Vol 50, Iss, Pp 102239-(2022)
In β-thalassemia, free α-globin chains are unstable and tend to aggregate or degrade, releasing toxic heme, porphyrins and iron, which produce reactive oxygen species (ROS). α-Hemoglobin-stabilizing protein (AHSP) is a potential modifier of β-tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d264e38265c1e484054facab0024f353
https://pubmed.ncbi.nlm.nih.gov/35092867
https://pubmed.ncbi.nlm.nih.gov/35092867
Autor:
Xiaohai Liu, Gaijing Han, Xinjie Bao, Kan Deng, Jun Gao, Wei Lian, Renzhi Wang, Xiang Lv, Liu Yang, Bing Xing, Ming Feng, Yong Yao
Publikováno v:
Journal of Cellular and Molecular Medicine
Metformin (MET) is a diabetes drug that activates AMP‐activated protein kinase (AMPK), and is suggested to have anticancer efficacy. Here, we investigated the role of AMPK signalling in prolactinoma (PRLoma), with particular respect to MET and brom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bec322bf5add523a1dc94b16e8f359b
https://doi.org/10.1111/jcmm.13963
https://doi.org/10.1111/jcmm.13963
Autor:
Zong-Yong Wu, Gaijing Han, Lanping Zhou, Xiaohang Zhao, Fangfei Niu, Nan Zhao, Yang Xu, Fang Liu
Publikováno v:
Oncotarget
// Gaijing Han 1, * , Zongyong Wu 2, * , Nan Zhao 1 , Lanping Zhou 1 , Fang Liu 1 , Fangfei Niu 1 , Yang Xu 1 and Xiaohang Zhao 1 1 State Key Laboratory of Molecular Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Science
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::793b8b742377672f7065fa413fb229e0
http://europepmc.org/articles/PMC5617461
http://europepmc.org/articles/PMC5617461
Autor:
Qiang Ju, Fang Liu, Nan Zhao, Yang Xu, Gaijing Han, Yousheng Mao, Xiaohang Zhao, Lanping Zhou
Publikováno v:
Oncotarget
// Nan Zhao 1, * , Yousheng Mao 2, * , Gaijing Han 1 , Qiang Ju 1 , Lanping Zhou 1 , Fang Liu 1 , Yang Xu 1 , Xiaohang Zhao 1 1 State Key Laboratory of Molecular Oncology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences & Peking Unio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ba5d577a187b4d50f6c8b2c12896942
https://doi.org/10.18632/oncotarget.4315
https://doi.org/10.18632/oncotarget.4315
Autor:
Gaijing Han, Lu Yan, Lianqi Sun, Liu Yonghua, Zongpan Jing, Fangfei Niu, Xiaohang Zhao, Yanbin Wu, Yang Xu, Laixing Hu, Lanping Zhou
Publikováno v:
Cancer letters. 420
Esophageal squamous cell carcinoma (ESCC) is one of the most common cancers worldwide due to its chemoresistance and poor prognosis. Currently, there is a lack of effective small molecule drugs for the treatment of ESCC. Microtubules are an attractiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f91b5a874480cf199835c876c264a30
https://pubmed.ncbi.nlm.nih.gov/29408653
https://pubmed.ncbi.nlm.nih.gov/29408653